Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for National Healthcare (NHC) over the last 16 years, with FY2024 value amounting to $100.3 million.

  • National Healthcare's Cash from Financing Activities fell 13373.74% to -$47.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$105.4 million, marking a year-over-year decrease of 19800.6%. This contributed to the annual value of $100.3 million for FY2024, which is 33585.38% up from last year.
  • As of FY2024, National Healthcare's Cash from Financing Activities stood at $100.3 million, which was up 33585.38% from -$42.5 million recorded in FY2023.
  • National Healthcare's 5-year Cash from Financing Activities high stood at $100.3 million for FY2024, and its period low was -$47.6 million during FY2022.
  • Over the past 5 years, National Healthcare's median Cash from Financing Activities value was -$41.9 million (recorded in 2020), while the average stood at -$13.4 million.
  • As far as peak fluctuations go, National Healthcare's Cash from Financing Activities crashed by 3510.1% in 2022, and later soared by 33585.38% in 2024.
  • Annual analysis of 5 years shows National Healthcare's Cash from Financing Activities stood at -$41.9 million in 2020, then rose by 15.82% to -$35.3 million in 2021, then tumbled by 35.1% to -$47.6 million in 2022, then rose by 10.7% to -$42.5 million in 2023, then soared by 335.85% to $100.3 million in 2024.
  • Its Cash from Financing Activities stands at $100.3 million for FY2024, versus -$42.5 million for FY2023 and -$47.6 million for FY2022.